☰

Agnieszka J. Szczepek, Ph.D. - Publications

Affiliations: 
2000 University of Alberta, Edmonton, Alberta, Canada 
Area:
Oncology, Cell Biology
Tree Info Grants Similar researchers PubMed Report error

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2002 Treon SP, Pilarski LM, Belch AR, Kelliher A, Preffer FI, Shima Y, Mitsiades CS, Mitsiades NS, Szczepek AJ, Ellman L, Harmon D, Grossbard ML, Anderson KC. CD20-directed serotherapy in patients with multiple myeloma: biologic considerations and therapeutic applications. Journal of Immunotherapy (Hagerstown, Md. : 1997). 25: 72-81. PMID 11924912  0.618
2001 Reiman T, Seeberger K, Taylor BJ, Szczepek AJ, Hanson J, Mant MJ, Coupland RW, Belch AR, Pilarski LM. Persistent preswitch clonotypic myeloma cells correlate with decreased survival: evidence for isotype switching within the myeloma clone. Blood. 98: 2791-9. PMID 11675353  0.577
2001 Szczepek AJ, Belch AR, Pilarski LM. Expression of IL-6 and IL-6 receptors by circulating clonotypic B cells in multiple myeloma: potential for autocrine and paracrine networks. Experimental Hematology. 29: 1076-81. PMID 11532348 DOI: 10.1016/S0301-472X(01)00682-8  0.534
2000 Pilarski LM, Giannakopoulos NV, Szczepek AJ, Masellis AM, Mant MJ, Belch AR. In multiple myeloma, circulating hyperdiploid B cells have clonotypic immunoglobulin heavy chain rearrangements and may mediate spread of disease Clinical Cancer Research. 6: 585-596. PMID 10690543  0.648
1998 Szczepek AJ, Seeberger K, Wizniak J, Mant MJ, Belch AR, Pilarski LM. A high frequency of circulating B cells share clonotypic Ig heavy-chain VDJ rearrangements with autologous bone marrow plasma cells in multiple myeloma, as measured by single-cell and in situ reverse transcriptase-polymerase chain reaction. Blood. 92: 2844-55. PMID 9763569  0.628
1997 Pilarski LM, Szczepek AJ, Belch AR. Deficient drug transporter function of bone marrow-localized and leukemic plasma cells in multiple myeloma. Blood. 90: 3751-9. PMID 9345062  0.572
1997 Szczepek AJ, Bergsagel PL, Axelsson L, Brown CB, Belch AR, Pilarski LM. CD34+ cells in the blood of patients with multiple myeloma express CD19 and IgH mRNA and have patient-specific IgH VDJ gene rearrangements. Blood. 89: 1824-33. PMID 9057669 DOI: 10.1182/Blood.V89.5.1824  0.653
1997 Szczepek A, Mant M, Belch A, Pilarski LM. Circulating CD19+ cells in multiple myeloma are clonaly related to the end stage malignant plasma cells in the bone marrow Immunology Letters. 56: 327. DOI: 10.1016/S0165-2478(97)86322-5  0.597
1995 Bergsagel P, Smith A, Szczepek A, Mant M, Belch A, Pilarski L. In multiple myeloma, clonotypic B lymphocytes are detectable among CD19+ peripheral blood cells expressing CD38, CD56, and monotypic Ig light chain [published erratum appears in Blood 1995 Jun 1;85(11):3365] Blood. 85: 436-447. DOI: 10.1182/Blood.V85.2.436.Bloodjournal852436  0.676
1994 Szczepek AJ, Belch AR, Pilarski LM. Interleukin-6 (IL-6) and interferon gamma (IFNγ) expression in peripheral blood lymphocytes (PBMC) from multiple myeloma patients Cytokine. 6: 570. DOI: 10.1016/1043-4666(94)90269-0  0.511
Show low-probability matches.